Published in PLoS One on December 05, 2014
Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br J Cancer (2016) 0.94
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol (2006) 3.13
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol (2009) 2.88
Epidemiology of inflammatory breast cancer (IBC). Breast Dis (2006) 2.46
Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat (2004) 2.42
Understanding breast cancer risk -- where do we stand in 2005? J Cell Mol Med (2005) 2.21
Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res (2004) 2.21
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study. Cancer (2010) 2.00
Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat (2012) 2.00
Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol (2006) 1.61
Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol (2009) 1.55
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res (2010) 1.47
The possible involvement of virus in breast cancer. J Cancer Res Clin Oncol (2008) 1.42
Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer (2010) 1.37
Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. J Clin Microbiol (2007) 1.36
Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One (2012) 1.28
Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev (2004) 1.27
A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol (2009) 1.25
Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer. Oncologist (2011) 1.22
Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. Semin Oncol (2008) 1.12
Detection of Epstein-Barr virus in breast carcinoma in Egyptian women. Clin Biochem (2008) 1.08
Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One (2009) 1.06
Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. Int J Cancer (2012) 1.06
Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res (2007) 1.05
Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol (2014) 1.03
THE MILK AGENT IN SPONTANEOUS MAMMARY CARCINOMA. Science (1944) 1.02
Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women. Cancer Res (2004) 1.01
Possible role of EBV in breast cancer and other unusually EBV-associated cancers. Cancer Lett (2010) 1.01
Human mammary tumor virus in inflammatory breast cancer. Cancer (2010) 0.98
Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients. PLoS One (2013) 0.98
Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer (2014) 0.98
Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients. Cancer Res (2013) 0.97
Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis. PLoS Med (2014) 0.95
Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer (2011) 0.94
Distribution of molecular breast cancer subtypes in middle eastern-saudi arabian women: a pilot study. Ultrastruct Pathol (2009) 0.89
Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS One (2012) 0.89
Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients. Breast Cancer Res Treat (2011) 0.88
Mouse mammary tumor virus-like virus infection and the risk of human breast cancer: a meta-analysis. Am J Transl Res (2014) 0.86
[Detection of Epstein-Barr virus in breast cancers with lymphoid stroma]. Ann Biol Clin (Paris) (2008) 0.85
Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies? Braz J Med Biol Res (2003) 0.83
Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas. J Gen Virol (2013) 0.82
Carcinogenic viruses and solid cancers without sufficient evidence of causal association. Int J Cancer (2013) 0.81
Mouse mammary tumor virus-like env sequences in human breast cancer. Int J Cancer (2008) 0.80
Nalidixic acid-resistant V79 cells with reduced DNA topoisomerase II activity and amplification prone phenotype. Mutat Res (1992) 0.79
Do viruses cause breast cancer? Methods Mol Biol (2009) 0.79
Detection of high-risk mucosal human papillomavirus DNA in human specimens by a novel and sensitive multiplex PCR method combined with DNA microarray. Methods Mol Biol (2011) 0.82
Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis. Int J Cancer (2016) 0.81
Prevalence and Transmission of Beta and Gamma Human Papillomavirus in Heterosexual Couples. Open Forum Infect Dis (2017) 0.81
Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia. Cancer Prev Res (Phila) (2016) 0.79
Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents. Oral Oncol (2016) 0.78
Mucosal and cutaneous human papillomaviruses in head and neck squamous cell papillomas. Head Neck (2016) 0.77
Autophagy regulates UBC9 levels during viral-mediated tumorigenesis. PLoS Pathog (2017) 0.75
Complete Genome Sequence of a Novel Human Betapapillomavirus Isolated from a Skin Sample. Genome Announc (2017) 0.75
Lichen Sclerosus in stable sexual partners: etiologic correlation or mere coincidence? G Ital Dermatol Venereol (2017) 0.75
Complete Genome Sequence of a Novel Human Gammapapillomavirus Isolated from Skin. Genome Announc (2017) 0.75
Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27]. Oral Oncol (2016) 0.75
Genome Sequence of a Novel Human Gammapapillomavirus Isolated from Skin. Genome Announc (2017) 0.75
Cutaneous beta human papillomaviruses and the development of male external genital lesions: A case-control study nested within the HIM Study. Virology (2016) 0.75